Obesity Clinical Trials in Baton Rouge, Louisiana

13 studies are recruiting for obesity in Baton Rouge, Louisiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

   This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection frac…

   Stage

   Phase 3

   Ages

   18 to 99

   Site

   Our Lady of the Lake Medical Center, Baton Rouge, Louisiana

   Locations

   657 in total

   Run by

   Amgen

   See if you can join NCT07037459 on ClinicalTrials.gov

2. A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

   Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term efficacy, safety, and tolerability of three maintenance doses of once-daily oral ASC30 compared with placebo in participants with obesity or overweight and…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   AURORA-2 Clinical Site, Baton Rouge, Louisiana

   Locations

   135 in total

   Run by

   Ascletis Pharma (China) Co., Limited

   See if you can join NCT07743450 on ClinicalTrials.gov

3. A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

   Study ASC30-301 (AURORA-1) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term efficacy, safety, and tolerability of three maintenance doses of once-daily oral ASC30 compared with placebo in participants with obesity or overweight wit…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   AURORA-1 Clinical Site, Baton Rouge, Louisiana

   Locations

   122 in total

   Run by

   Ascletis Pharma (China) Co., Limited

   See if you can join NCT07743463 on ClinicalTrials.gov

4. Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

   The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with obesity or overweight. Trial 20250197 is an extension of trial 20210181 (NCT06858839).

   Stage

   Phase 3

   Ages

   18 to 99

   Site

   Velocity Clinical Research - Baton Rouge, Baton Rouge, Louisiana

   Locations

   87 in total

   Run by

   Amgen

   See if you can join NCT07684235 on ClinicalTrials.gov

5. A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

   This study will look at how well CagriSema and cagrilintide help children and adolescents with excess body weight lose weight. The study has 2 parts: main and extension study. In the main study, participants will either get CagriSema (a new study drug), cagrilintide (a new study drug), semaglutide …

   Stage

   Phase 3

   Ages

   8 to 18

   Site

   Pennington Biomed Res Ctr, Baton Rouge, Louisiana

   Locations

   121 in total

   Run by

   Novo Nordisk A/S

   See if you can join NCT07253285 on ClinicalTrials.gov

6. GLP-1R Actions on Muscle and the Skeleton

   The GRAMS study objectives are to assess the musculoskeletal changes that occur after weight loss using GLP-1 based therapy. A lifestyle intervention with diet and exercise is included to assess any mitigating effects are provided, versus a control group with regular exercise and diet.

   Stage

   Phase 4

   Ages

   18 to 50

   Site

   Pennington Biomedical Research Center, Baton Rouge, Louisiana

   Locations

   2 in total

   Run by

   Pennington Biomedical Research Center

   See if you can join NCT07154719 on ClinicalTrials.gov

7. Collaborative Multi-level Obesity Intervention Engaging Communities Trial

   The goal of this clinical trial is to test the effectiveness of an evidence-based multi-level intervention for weight loss and the feasibility, fidelity, and sustainability of implementing the intervention in people living with obesity in Louisiana. The main questions it aims to answer are: * Will …

   Stage

   Not phased

   Ages

   18 to 75

   Site

   CareSouth Medical and Dental - Baton Rouge Clinic, Baton Rouge, Louisiana

   Locations

   18 in total

   Run by

   Tulane University

   See if you can join NCT06835686 on ClinicalTrials.gov

8. Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

   Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses of aleniglipron once daily (QD) compared with placebo, when used in combination with a reduced-calo…

   Stage

   Phase 3

   Ages

   18 to 79

   Site

   ACCOMPLISH-1 Research Site, Baton Rouge, Louisiana

   Locations

   71 in total

   Run by

   Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

   See if you can join NCT07654361 on ClinicalTrials.gov

9. Low Oxygen Exposure and Weight Status

   The objective of the proposed double-blind, parallel-arm, randomized clinical trial is to evaluate changes in body weight and composition, assess determinants of energy balance (intake and expenditure), and measure modulators of energy balance, following 8 wk of calorie restriction (-500 kcal/d) in…

   Stage

   Not phased

   Ages

   22 to 65

   Site

   Pennington Biomedical Research Center, Baton Rouge, Louisiana

   Run by

   Pennington Biomedical Research Center

   See if you can join NCT05289310 on ClinicalTrials.gov

10. Body Composition Outcomes in MS Patients

    Objectives The objective of this project is to generate pilot data substantiating our hypothesis that advanced body composition measurement tools will provide more accurate and clinically relevant data on the outcomes of metabolic surgery (MS) in patients with severe obesity compared to traditional…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Pennington Biomedical Research Center, Baton Rouge, Louisiana

    Locations

    2 in total

    Run by

    Pennington Biomedical Research Center

    See if you can join NCT07530718 on ClinicalTrials.gov

11. Experimental Approach to Test Predictions of Body Weight Regulation Models

    The regulation of human body weight and fatness is not fully understood. Although some models of regulation have been proposed (set point, dual-intervention point, others), no studies have been designed to test their predictions. In this pilot and feasibility study, the investigators will implement…

    Stage

    Not phased

    Ages

    18 to 40

    Site

    Pennington Biomedical Research Center, Baton Rouge, Louisiana

    Run by

    Pennington Biomedical Research Center

    See if you can join NCT06309576 on ClinicalTrials.gov

12. Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

    The purpose of this research study is to study the effects of endurance exercise training on adipose (fat) tissue quality and insulin sensitivity in men and women.

    Stage

    Not phased

    Ages

    18 to 45

    Site

    Pennington Biomedical Research Center, Baton Rouge, Louisiana

    Locations

    2 in total

    Run by

    AdventHealth Translational Research Institute

    See if you can join NCT06602141 on ClinicalTrials.gov

13. International Weight Control Registry

    The IWCR is a global scientific study aimed at better understanding the opportunities and barriers for reducing the prevalence of obesity by collecting information from people who have experience with weight management in their everyday lives. The investigators seek to gather information on a wide …

    Stage

    Not phased

    Ages

    18 and older

    Site

    Pennington Biomedical Research Center, Baton Rouge, Louisiana

    Locations

    7 in total

    Run by

    Tufts University

    See if you can join NCT04907396 on ClinicalTrials.gov